GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 94 filers reported holding GALENA BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $65,000 | -22.6% | 185,945 | +3.6% | 0.00% | – |
| Q2 2016 | $84,000 | -62.0% | 179,495 | +10.6% | 0.00% | -100.0% |
| Q1 2016 | $221,000 | -6.4% | 162,220 | +0.9% | 0.00% | 0.0% |
| Q4 2015 | $236,000 | +2.2% | 160,845 | +10.2% | 0.00% | 0.0% |
| Q3 2015 | $231,000 | -3.3% | 145,995 | +3.8% | 0.00% | 0.0% |
| Q2 2015 | $239,000 | +38.2% | 140,600 | +12.9% | 0.00% | – |
| Q1 2015 | $173,000 | +12.3% | 124,585 | +21.8% | 0.00% | – |
| Q4 2014 | $154,000 | -24.9% | 102,285 | +2.9% | 0.00% | -100.0% |
| Q3 2014 | $205,000 | -34.1% | 99,410 | -2.1% | 0.00% | 0.0% |
| Q2 2014 | $311,000 | +44.7% | 101,510 | +18.2% | 0.00% | 0.0% |
| Q1 2014 | $215,000 | -51.8% | 85,901 | -4.5% | 0.00% | 0.0% |
| Q4 2013 | $446,000 | +129.9% | 89,971 | +5.3% | 0.00% | 0.0% |
| Q3 2013 | $194,000 | +14.8% | 85,471 | +12.4% | 0.00% | 0.0% |
| Q2 2013 | $169,000 | – | 76,010 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,446,469 | $13,616,000 | 2.03% |
| Harbour Capital Advisors, LLC | 78,450 | $196,000 | 0.19% |
| SABBY MANAGEMENT, LLC | 708,089 | $1,770,000 | 0.10% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 174,600 | $437,000 | 0.07% |
| Alyeska Investment Group, L.P. | 530,000 | $1,950,000 | 0.05% |
| HIGHLAND CAPITAL MANAGEMENT LP | 528,027 | $1,320,000 | 0.05% |
| KMS FINANCIAL SERVICES, INC | 118,042 | $295,000 | 0.05% |
| Quantitative Investment Management, LLC | 348,500 | $871,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 538,100 | $1,345,000 | 0.04% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $74,000 | 0.04% |